We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Biyolojik tedaviler.
- Authors
Gülbezer, Elif Er; Keser, Gökhan
- Abstract
Biological treatments are the medications which specifically target one of the immunological or genetic mediators involved in the patho- genesis of a disease. The number and spectrum of biological agents, which require advanced technology and cost highly, are constantly increasing. The biological agents that are commonly used in rheuma- tology include anti-TNF inhibitors, IL-1 p inhibitors, tocilizumab which inhibits IL-6R, rituximab RTX which depletes B cells and abatacept which is a T cell co-stimulation inhibitor. Besides, there are also new biological agents to be used in the near future. They constitute an important treatment alternative for the disease groups such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, juvenile idiopathic arthritis, familial Mediterranean fever, adult Still's disease and ANCA-associated systemic vasculitis, especially for the patients who are resistant to conventional therapies.
- Publication
RAED Journal / RAED Dergisi, 2017, Vol 9, Issue 1/2, p11
- ISSN
1301-4021
- Publication type
Article
- DOI
10.2399/raed.17.92400